发明名称 EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT
摘要 A pharmaceutical composition includes a therapeutically effective amount of exo-R-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of exo-S-mecamylamine in combination with a pharmaceutically acceptable carrier. Preferably the amount is about 0.5 mg to about 20 mg. Medical conditions are treated by administering a therapeutically effective amount of exo-R-mecamylamine or a pharmaceutically acceptable salt thereof, substantially free of its exo-S-mecamylamine, said amount being sufficient to ameliorate the medical condition. The medical conditions include but are not limited to substance addiction (involving nicotine, cocaine, alcohol, amphetamine, opiate, other psychostimulant and a combination thereof), aiding smoking cessation, treating weight gain associated with smoking cessation, hypertension, hypertensive crisis, Tourette's Syndrome and other tremors, cancer (such as small cell lung cancer), atherogenic profile, neuropsychiatric disorders (such as bipolar disorder, depression, an anxiety disorder, schizophrenia, a seizure disorders, Parkinson's disease and attention deficit hyperactivity disorder), chronic fatigue syndrome, Crohn's disease, autonomic dysreflexia, and spasmogenic intestinal disorders.
申请公布号 WO0035280(A1) 申请公布日期 2000.06.22
申请号 WO1999US30137 申请日期 1999.12.16
申请人 UNIVERSITY OF SOUTH FLORIDA;SHYTLE, DOUGLAS;SANBERG, PAUL;NEWMAN, MARY;SILVER, ARCHIE 发明人 SHYTLE, DOUGLAS;SANBERG, PAUL;NEWMAN, MARY;SILVER, ARCHIE
分类号 A61K9/06;A01N33/02;A01N33/18;A01N33/24;A61K9/08;A61K9/22;A61K9/52;A61K31/015;A61K31/13;A61P1/04;A61P1/06;A61P3/02;A61P9/12;A61P25/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P35/00;A61P37/08;C07C209/88;C07C211/34;C07D217/26;(IPC1-7):A01N33/18 主分类号 A61K9/06
代理机构 代理人
主权项
地址